NASDAQ:CGEM | Insider Transactions | Cullinan Therapeutics, Inc.

CGEM Insider Transactions

386 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.

CGEM insiders transaction timeline

PurchaseSale
2021-01-12: 25 purchases — MPM Oncology Impact Management LP, UBS Oncology Impact Fund L.P., MPM Oncology Impact Management GP LLC and 13 more2021-08-09: 4 sales — Zawel Leigh2021-08-10: 7 sales — Zawel Leigh, Baeuerle Patrick2021-08-11: 6 sales — MPM Oncology Impact Management LP, UBS Oncology Impact Fund L.P., MPM Oncology Impact Management GP LLC and 2 more2021-08-18: 4 sales — Michaelson Jennifer2021-08-23: 8 sales — Zawel Leigh, MPM Oncology Impact Management LP, UBS Oncology Impact Fund L.P. and 3 more2021-08-24: 6 sales — MPM Oncology Impact Management LP, UBS Oncology Impact Fund L.P., MPM Oncology Impact Management GP LLC and 2 more2021-08-25: 6 sales — MPM Oncology Impact Management LP, UBS Oncology Impact Fund L.P., MPM Oncology Impact Management GP LLC and 2 more2021-08-27: 5 sales — GADICKE ANSBERT, BioImpact Capital LLC, UBS Oncology Impact Fund L.P. and 1 more2021-08-30: 5 sales — GADICKE ANSBERT, BioImpact Capital LLC, UBS Oncology Impact Fund L.P. and 1 more2021-08-31: 10 sales — BioImpact Capital LLC, UBS Oncology Impact Fund L.P., Oncology Impact Fund (Cayman) Management L.P. and 1 more2021-09-01: 5 sales — BioImpact Capital LLC, UBS Oncology Impact Fund L.P., Oncology Impact Fund (Cayman) Management L.P. and 1 more2021-09-02: 5 sales — BioImpact Capital LLC, UBS Oncology Impact Fund L.P., Oncology Impact Fund (Cayman) Management L.P. and 1 more2021-09-03: 5 sales — BioImpact Capital LLC, UBS Oncology Impact Fund L.P., Oncology Impact Fund (Cayman) Management L.P. and 1 more2021-09-07: 6 sales — BioImpact Capital LLC, UBS Oncology Impact Fund L.P., Oncology Impact Fund (Cayman) Management L.P. and 2 more2021-09-08: 8 sales — Trigilio Jeffrey, Baeuerle Patrick, BioImpact Capital LLC and 3 more2021-09-09: 5 sales — BioImpact Capital LLC, UBS Oncology Impact Fund L.P., Oncology Impact Fund (Cayman) Management L.P. and 1 more2021-09-10: 5 sales — BioImpact Capital LLC, UBS Oncology Impact Fund L.P., Oncology Impact Fund (Cayman) Management L.P. and 1 more2021-09-13: 5 sales — BioImpact Capital LLC, UBS Oncology Impact Fund L.P., Oncology Impact Fund (Cayman) Management L.P. and 1 more2021-09-14: 5 sales — BioImpact Capital LLC, UBS Oncology Impact Fund L.P., Oncology Impact Fund (Cayman) Management L.P. and 1 more2021-09-15: 5 sales — BioImpact Capital LLC, UBS Oncology Impact Fund L.P., Oncology Impact Fund (Cayman) Management L.P. and 1 more2021-09-16: 5 sales — BioImpact Capital LLC, UBS Oncology Impact Fund L.P., Oncology Impact Fund (Cayman) Management L.P. and 1 more2021-09-20: 3 sales — Michaelson Jennifer, Zawel Leigh2021-10-07: 1 sale — Zawel Leigh2021-10-15: 2 sales — Trigilio Jeffrey, Zawel Leigh2021-10-18: 3 sales — Michaelson Jennifer2022-04-01: 20 purchases — BIOTECHNOLOGY VALUE FUND L P, BVF PARTNERS L P/IL, BVF INC/IL and 7 more2022-05-12: 20 purchases — BIOTECHNOLOGY VALUE FUND L P, BVF PARTNERS L P/IL, BVF INC/IL and 7 more2022-05-12: 2 sales — Jovan-Embiricos Morana, F2 Vision SCS2022-05-13: 30 purchases — BIOTECHNOLOGY VALUE FUND L P, BVF PARTNERS L P/IL, BVF INC/IL and 7 more2022-05-13: 4 sales — Jovan-Embiricos Morana, F2 Vision SCS2022-05-16: 2 sales — Jovan-Embiricos Morana, F2 Vision SCS2022-06-01: 30 purchases — BIOTECHNOLOGY VALUE FUND L P, BVF PARTNERS L P/IL, BVF INC/IL and 7 more2022-06-06: 1 purchase — AHMED NADIM2022-06-21: 2 sales — Jovan-Embiricos Morana, F2 Bioscience I 2017 Ltd2022-06-22: 2 sales — Jovan-Embiricos Morana, F2 Bioscience I 2017 Ltd2022-06-23: 2 sales — Jovan-Embiricos Morana, F2 Bioscience I 2017 Ltd2022-07-11: 2 sales — Savill Corrine2022-07-18: 1 sale — Savill Corrine2022-07-19: 1 sale — Savill Corrine2022-07-25: 1 sale — Michaelson Jennifer2022-08-02: 2 sales — Jovan-Embiricos Morana, F2 Vision SCS2022-08-03: 2 sales — Jovan-Embiricos Morana, F2 Vision SCS2022-08-04: 2 sales — Jovan-Embiricos Morana, F2 Vision SCS2022-08-08: 1 sale — Michaelson Jennifer2022-09-27: 1 sale — Michaelson Jennifer2022-11-25: 1 sale — Michaelson Jennifer2023-03-20: 4 sales — Trigilio Jeffrey, Jones Jeffrey Alan, Michaelson Jennifer and 1 more2023-03-23: 1 sale — AHMED NADIM2023-04-12: 2 sales — Trigilio Jeffrey, Michaelson Jennifer2023-04-18: 4 sales — Jones Jeffrey Alan, Trigilio Jeffrey, Michaelson Jennifer and 1 more2023-04-25: 1 sale — AHMED NADIM2023-05-12: 2 sales — Michaelson Jennifer, Trigilio Jeffrey2023-05-18: 4 sales — Michaelson Jennifer, Jones Jeffrey Alan, SUMER JACQUELYN L and 1 more2023-05-23: 1 sale — AHMED NADIM2023-06-06: 1 sale — Michaelson Jennifer2023-06-07: 1 sale — Michaelson Jennifer2023-06-12: 2 sales — Trigilio Jeffrey, Michaelson Jennifer2023-06-20: 4 sales — Jones Jeffrey Alan, Michaelson Jennifer, Trigilio Jeffrey and 1 more2023-06-28: 1 sale — AHMED NADIM2023-12-12: 2 sales — Trigilio Jeffrey, Michaelson Jennifer2023-12-18: 4 sales — Michaelson Jennifer, Jones Jeffrey Alan, SUMER JACQUELYN L and 1 more2023-12-21: 4 sales — Jones Jeffrey Alan, SUMER JACQUELYN L, Trigilio Jeffrey and 1 more2023-12-26: 1 sale — AHMED NADIM2024-01-22: 2 sales — Savill Corrine2024-01-23: 1 sale — Savill Corrine2024-01-29: 1 sale — Savill Corrine2024-02-01: 1 sale — Savill Corrine2024-05-06: 2 sales — Michaelson Jennifer2024-05-07: 1 sale — Michaelson Jennifer2024-07-05: 1 sale — Michaelson Jennifer2024-09-05: 1 sale — Michaelson Jennifer2024-11-05: 1 sale — Michaelson Jennifer2024-12-12: 1 sale — Michaelson Jennifer2024-12-18: 3 sales — Michaelson Jennifer, Jones Jeffrey Alan, SUMER JACQUELYN L2024-12-24: 1 sale — AHMED NADIM2025-01-06: 1 sale — Michaelson Jennifer2025-02-25: 4 sales — Jones Jeffrey Alan, Michaelson Jennifer, AHMED NADIM and 1 more2025-10-08: 2 purchases — Nichols Weston, Lynx1 Capital Management LP2025-10-09: 2 purchases — Nichols Weston, Lynx1 Capital Management LP2025-10-10: 2 purchases — Nichols Weston, Lynx1 Capital Management LP2025-10-14: 2 purchases — Nichols Weston, Lynx1 Capital Management LP2025-10-15: 2 purchases — Nichols Weston, Lynx1 Capital Management LP2025-10-16: 2 purchases — Nichols Weston, Lynx1 Capital Management LP2025-10-17: 2 purchases — Nichols Weston, Lynx1 Capital Management LP2025-10-28: 2 purchases — Nichols Weston, Lynx1 Capital Management LP2025-11-24: 1 sale — Michaelson Jennifer2025-12-12: 1 sale — Michaelson Jennifer2025-12-15: 1 sale — Michaelson Jennifer2025-12-18: 3 sales — SUMER JACQUELYN L, Jones Jeffrey Alan, Michaelson Jennifer2025-12-19: 1 sale — Michaelson Jennifer2025-12-23: 1 sale — AHMED NADIM2026-01-22: 1 sale — Michaelson Jennifer2026-02-12: 1 sale — Michaelson Jennifer2026-02-20: 6 sales — Fenton Mary Kay, Jones Jeffrey Alan, Michaelson Jennifer and 2 more2026-02-23: 1 sale — Michaelson Jennifer2026-02-24: 4 sales — Michaelson Jennifer, AHMED NADIM, Jones Jeffrey Alan and 1 more2026-02-25: 1 sale — Michaelson Jennifer2026-03-05: 1 sale — Michaelson Jennifer2026-05-05: 2 sales — Michaelson Jennifer2026-07-06: 1 sale — Michaelson Jennifer2026-08-13: 1 sale — Michaelson Jennifer2021-01-122026-08-13
Insider profileRoleDateTransactionSharesPrice
Michaelson JenniferChief Scientific Officer2026-08-13Sale30,000$20.26
Michaelson JenniferChief Scientific Officer2026-07-06Sale8,000$17.82
Michaelson JenniferChief Scientific Officer2026-05-05Sale200.0$15.58
Michaelson JenniferChief Scientific Officer2026-05-05Sale7,800.0$14.6
Michaelson JenniferChief Scientific Officer2026-03-05Sale8,000.0$15.68
Michaelson JenniferChief Scientific Officer2026-02-25Sale1,780.0$14.14
Michaelson JenniferChief Scientific Officer2026-02-24Sale3,601.0$14.47
AHMED NADIMPresident and CEO2026-02-24Sale13,515.0$14.47
Jones Jeffrey AlanChief Medical Officer2026-02-24Sale4,582.0$14.47
SUMER JACQUELYN LChief Legal Officer2026-02-24Sale3,601.0$14.47
Michaelson JenniferChief Scientific Officer2026-02-23Sale1,752.0$13.99
Fenton Mary KayChief Financial Officer2026-02-20Sale4,398.0$13.62
Jones Jeffrey AlanChief Medical Officer2026-02-20Sale4,982.0$13.62
Michaelson JenniferChief Scientific Officer2026-02-20Sale8,000.0$14.3
Michaelson JenniferChief Scientific Officer2026-02-20Sale3,742.0$13.62
SUMER JACQUELYN LChief Legal Officer2026-02-20Sale3,742.0$13.62
AHMED NADIMPresident and CEO2026-02-20Sale16,381.0$13.62
Michaelson JenniferChief Scientific Officer2026-02-12Sale416.0$12.03
Michaelson JenniferChief Scientific Officer2026-01-22Sale4,000.0$12.3
AHMED NADIMPresident and CEO2025-12-23Sale9,922.0$10.01
Michaelson JenniferChief Scientific Officer2025-12-19Sale1,345.0$10.01
SUMER JACQUELYN LChief Legal Officer2025-12-18Sale3,480.0$9.67
Jones Jeffrey AlanChief Medical Officer2025-12-18Sale4,632.0$9.67
Michaelson JenniferChief Scientific Officer2025-12-18Sale2,898.0$9.67
Michaelson JenniferChief Scientific Officer2025-12-15Sale995.0$11.9
Michaelson JenniferChief Scientific Officer2025-12-12Sale2,148.0$12.38
Michaelson JenniferChief Scientific Officer2025-11-24Sale4,000.0$12.3
Nichols WestonTenPercentOwner2025-10-28Purchase165,667.0$8.4
Lynx1 Capital Management LPTenPercentOwner2025-10-28Purchase165,667.0$8.4
Nichols WestonTenPercentOwner2025-10-17Purchase32,217.0$7.84
Lynx1 Capital Management LPTenPercentOwner2025-10-17Purchase32,217.0$7.84
Nichols WestonTenPercentOwner2025-10-16Purchase150,000.0$8.86
Lynx1 Capital Management LPTenPercentOwner2025-10-16Purchase150,000.0$8.86
Nichols WestonTenPercentOwner2025-10-15Purchase51,500.0$7.94
Lynx1 Capital Management LPTenPercentOwner2025-10-15Purchase51,500.0$7.94
Nichols WestonTenPercentOwner2025-10-14Purchase15,032.0$7.59
Lynx1 Capital Management LPTenPercentOwner2025-10-14Purchase15,032.0$7.59
Nichols WestonTenPercentOwner2025-10-10Purchase277,298.0$7.36
Lynx1 Capital Management LPTenPercentOwner2025-10-10Purchase277,298.0$7.36
Nichols WestonTenPercentOwner2025-10-09Purchase626,043.0$6.7
Lynx1 Capital Management LPTenPercentOwner2025-10-09Purchase626,043.0$6.7
Nichols WestonTenPercentOwner2025-10-08Purchase556,300.0$6.46
Lynx1 Capital Management LPTenPercentOwner2025-10-08Purchase556,300.0$6.46
Jones Jeffrey AlanChief Medical Officer2025-02-25Sale4,895.0$8.53
Michaelson JenniferChief Scientific Officer2025-02-25Sale3,756.0$8.53
AHMED NADIMPresident and CEO2025-02-25Sale12,529.0$8.53
SUMER JACQUELYN LChief Legal Officer2025-02-25Sale3,756.0$8.53
Michaelson JenniferChief Scientific Officer2025-01-06Sale4,000.0$12.51
AHMED NADIMPresident and CEO2024-12-24Sale8,400.0$11.87
Michaelson JenniferChief Scientific Officer2024-12-18Sale4,693.0$11.41
Jones Jeffrey AlanChief Medical Officer2024-12-18Sale4,632.0$11.41
SUMER JACQUELYN LChief Legal Officer2024-12-18Sale3,482.0$11.41
Michaelson JenniferChief Scientific Officer2024-12-12Sale3,489.0$12.52
Michaelson JenniferChief Scientific Officer2024-11-05Sale8,000.0$15.64
Michaelson JenniferChief Scientific Officer2024-09-05Sale8,000.0$18.09
Michaelson JenniferChief Scientific Officer2024-07-05Sale8,000.0$16.33
Michaelson JenniferChief Scientific Officer2024-05-07Sale5,606.0$30.06
Michaelson JenniferChief Scientific Officer2024-05-06Sale20,277.0$28.54
Michaelson JenniferChief Scientific Officer2024-05-06Sale37,723.0$27.82
Savill CorrineChief Business Officer2024-02-01Sale40,000.0$16.18
Savill CorrineChief Business Officer2024-01-29Sale40,000.0$14.09
Savill CorrineChief Business Officer2024-01-23Sale21,316.0$12.46
Savill CorrineChief Business Officer2024-01-22Sale4,125.0$12.02
Savill CorrineChief Business Officer2024-01-22Sale14,559.0$12.18
AHMED NADIMPresident and CEO2023-12-26Sale4,272.0$9.24
Jones Jeffrey AlanChief Medical Officer2023-12-21Sale1,860.0$8.5
SUMER JACQUELYN LChief Legal Officer2023-12-21Sale1,400.0$8.5
Trigilio JeffreyChief Financial Officer2023-12-21Sale1,920.0$8.5
Michaelson JenniferChief Scientific Officer2023-12-21Sale1,145.0$8.5
Michaelson JenniferChief Scientific Officer2023-12-18Sale238.0$8.22
Jones Jeffrey AlanChief Medical Officer2023-12-18Sale386.0$8.22
SUMER JACQUELYN LChief Legal Officer2023-12-18Sale290.0$8.22
Trigilio JeffreyChief Financial Officer2023-12-18Sale398.0$8.22
Trigilio JeffreyChief Financial Officer2023-12-12Sale1,926.0$7.81
Michaelson JenniferChief Scientific Officer2023-12-12Sale1,068.0$7.81
AHMED NADIMPresident and CEO2023-06-28Sale759.0$11.4
Jones Jeffrey AlanChief Medical Officer2023-06-20Sale387.0$12.94
Michaelson JenniferChief Development Officer2023-06-20Sale238.0$12.94
Trigilio JeffreyChief Financial Officer2023-06-20Sale399.0$12.94
SUMER JACQUELYN LChief Legal Officer2023-06-20Sale291.0$12.94
Trigilio JeffreyChief Financial Officer2023-06-12Sale319.0$13.11
Michaelson JenniferChief Development Officer2023-06-12Sale176.0$13.11
Michaelson JenniferChief Development Officer2023-06-07Sale100.0$12.4
Michaelson JenniferChief Development Officer2023-06-06Sale11,900.0$12.31
AHMED NADIMPresident and CEO2023-05-23Sale707.0$9.15
Michaelson JenniferChief Development Officer2023-05-18Sale239.0$8.76
Jones Jeffrey AlanChief Medical Officer2023-05-18Sale394.0$8.76
SUMER JACQUELYN LChief Legal Officer2023-05-18Sale291.0$8.76
Trigilio JeffreyChief Financial Officer2023-05-18Sale399.0$8.76
Michaelson JenniferChief Development Officer2023-05-12Sale193.0$8.78
Trigilio JeffreyChief Financial Officer2023-05-12Sale347.0$8.78
AHMED NADIMPresident and CEO2023-04-25Sale716.0$10.59
Jones Jeffrey AlanChief Medical Officer2023-04-18Sale392.0$10.71
Trigilio JeffreyChief Financial Officer2023-04-18Sale398.0$10.71
Michaelson JenniferChief Development Officer2023-04-18Sale238.0$10.71
SUMER JACQUELYN LChief Legal Officer2023-04-18Sale290.0$10.71
Trigilio JeffreyChief Financial Officer2023-04-12Sale318.0$10.22
Michaelson JenniferChief Development Officer2023-04-12Sale176.0$10.22
AHMED NADIMPresident and CEO2023-03-23Sale706.0$10.51
Trigilio JeffreyChief Financial Officer2023-03-20Sale399.0$11.32